Age | Median (range) | 67 (49-80) |
---|---|---|
IPSS status (before BT) | mean (SD) | 3.6 (3.5) |
median (range) | 3 (0-17) | |
P25-P75 | 1-5 | |
Technique | free seeds | 69 (34.8%) |
FIRST | 129 (65.2%) | |
Risk group (D'Amico) | Low risk | 141 (71.2%) |
Intermediate risk | 57 (28.8%) | |
Pre-BT PSA | median (range) | 7.2 (0.4 - 18.4) |
P25-P75 | 5.5 - 8.7 | |
Per-op. dosimetric data | ||
Prostate volume | median (range) | 35 (14 - 61.9) |
P25-P75 | 27.8 - 40.4 | |
D95% | median (range) | 166 (105-220) |
P25-P75 | 154-180 | |
D90% | median (range) | 182 (131-235) |
P25-P75 | 171-195 | |
V144Gy | median (range) | 98.4 (82.7-100) |
P25-P75 | 96.8-99.5 | |
# seeds | median (range) | 74 (40-120) |
P25-P75 | 63-83 | |
Seeds density (N/cc) | median (range) | 2.1 (1.5-4.0) |
P25-P75 | 1.9-2.4 |